<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/"><channel><title>PeptideScanner evidence for Motixafortide</title><link>https://peptidescanner.com/peptides/motixafortide/</link><description>Versioned, source-linked PeptideScanner evidence objects for Motixafortide. Selected coverage; not medical advice.</description><language>en-us</language><atom:link href="https://peptidescanner.com/feeds/peptides/motixafortide.xml" rel="self" type="application/rss+xml"/><item><title>ClinicalTrials.gov record NCT04543071</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct04543071-motixafortide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct04543071-motixafortide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/motixafortide.json#clinicaltrials-gov-nct04543071-motixafortide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2026-09-21. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT05618301</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct05618301-motixafortide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct05618301-motixafortide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/motixafortide.json#clinicaltrials-gov-nct05618301-motixafortide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2025-08-11. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT06442761</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct06442761-motixafortide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct06442761-motixafortide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/motixafortide.json#clinicaltrials-gov-nct06442761-motixafortide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2026-09-08. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT06506461</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct06506461-motixafortide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct06506461-motixafortide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/motixafortide.json#clinicaltrials-gov-nct06506461-motixafortide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2026-10-15. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT06547112</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct06547112-motixafortide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct06547112-motixafortide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/motixafortide.json#clinicaltrials-gov-nct06547112-motixafortide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2025-08-29. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT07101445</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct07101445-motixafortide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct07101445-motixafortide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/motixafortide.json#clinicaltrials-gov-nct07101445-motixafortide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2026-07-23. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT07392970</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct07392970-motixafortide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct07392970-motixafortide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/motixafortide.json#clinicaltrials-gov-nct07392970-motixafortide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2026-07-24. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>Drugs@FDA application NDA217159</title><link>https://peptidescanner.com/stories/fda-drugs-nda217159/</link><guid isPermaLink="false">urn:peptidescanner:story:fda-drugs-nda217159:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/motixafortide.json#fda-drugs-nda217159-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Regulatory; date in source 2023-09-08. PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.</description><dc:date>2026-11-16</dc:date><category>Regulatory</category><category>Lifecycle state: current</category></item><item><title>Motixafortide and Pembrolizumab Combined to Nanoliposomal Irinotecan, Fluorouracil, and Folinic Acid in Metastatic Pancreatic Cancer: The COMBAT/KEYNOTE-202 Trial.</title><link>https://peptidescanner.com/stories/pubmed-pmid-34253578-motixafortide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-34253578-motixafortide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/motixafortide.json#pubmed-pmid-34253578-motixafortide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2022-04-01. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Structural Basis of the Binding Mode of the Antineoplastic Compound Motixafortide (BL-8040) in the CXCR4 Chemokine Receptor.</title><link>https://peptidescanner.com/stories/pubmed-pmid-36901829-motixafortide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-36901829-motixafortide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/motixafortide.json#pubmed-pmid-36901829-motixafortide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2023-03-14. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Motixafortide and G-CSF to mobilize hematopoietic stem cells for autologous transplantation in multiple myeloma: a randomized phase 3 trial.</title><link>https://peptidescanner.com/stories/pubmed-pmid-37069359-motixafortide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-37069359-motixafortide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/motixafortide.json#pubmed-pmid-37069359-motixafortide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-11-09. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Motixafortide Acetate.</title><link>https://peptidescanner.com/stories/pubmed-pmid-37862457-motixafortide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-37862457-motixafortide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/motixafortide.json#pubmed-pmid-37862457-motixafortide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2024-10-09. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>A comparative review of Aphexda and Mozobil for mobilization prior to stem cell collection.</title><link>https://peptidescanner.com/stories/pubmed-pmid-38629183-motixafortide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-38629183-motixafortide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/motixafortide.json#pubmed-pmid-38629183-motixafortide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2024-10-30. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Development and Validation of the LC-MS/MS Method and Its Application for Pharmacokinetic Studies for the Simultaneous Estimation of Motixafortide and Filgrastim in rat Plasma.</title><link>https://peptidescanner.com/stories/pubmed-pmid-40420423-motixafortide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-40420423-motixafortide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/motixafortide.json#pubmed-pmid-40420423-motixafortide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2025-05-27. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Atezolizumab and motixafortide, cobimetinib or simlukafusp alfa in pretreated advanced pancreatic cancer: phase I/IIb MORPHEUS-PDAC umbrella study.</title><link>https://peptidescanner.com/stories/pubmed-pmid-41741368-motixafortide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-41741368-motixafortide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/motixafortide.json#pubmed-pmid-41741368-motixafortide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-08-13. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Comparative analysis of motixafortide versus plerixafor for stem cell mobilization and collection in multiple myeloma: A single center real-world experience.</title><link>https://peptidescanner.com/stories/pubmed-pmid-42435378-motixafortide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-42435378-motixafortide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/motixafortide.json#pubmed-pmid-42435378-motixafortide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-07-11. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Motixafortide, cemiplimab, gemcitabine and nab-paclitaxel in metastatic pancreatic cancer: a single-arm phase 2 study with single-cell correlatives.</title><link>https://peptidescanner.com/stories/pubmed-pmid-42811017-motixafortide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-42811017-motixafortide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/motixafortide.json#pubmed-pmid-42811017-motixafortide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-11-09. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item></channel></rss>
